States Fight Sandoz Bid To Argue Duplication In Generics Row
By Matthew Santoni · December 15, 2025, 7:54 PM EST
Multiple attorneys general have told a Connecticut federal court that Sandoz Inc. and Fougera Pharmaceuticals Inc. can't claim the states' grievances over allegations of price-fixing are duplicative of claims that were...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login